| Literature DB >> 26808978 |
Kobina Assan Ampah1,2,3, Beatrice Nickel1,2, Prince Asare3, Amanda Ross1,2, Daniel De-Graft3, Sarah Kerber1,2, Ralf Spallek4, Mahavir Singh4, Gerd Pluschke1,2, Dorothy Yeboah-Manu3, Katharina Röltgen1,2.
Abstract
The debilitating skin disease Buruli ulcer (BU) is caused by infection with Mycobacterium ulcerans. While various hypotheses on potential reservoirs and vectors of M. ulcerans exist, the mode of transmission has remained unclear. Epidemiological studies have indicated that children below the age of four are less exposed to the pathogen and at lower risk of developing BU than older children. In the present study we compared the age at which children begin to develop antibody responses against M. ulcerans with the age pattern of responses to other pathogens transmitted by various mechanisms. A total of 1,352 sera from individuals living in the BU endemic Offin river valley of Ghana were included in the study. While first serological responses to the mosquito transmitted malaria parasite Plasmodium falciparum and to soil transmitted Strongyloides helminths emerged around the age of one and two years, sero-conversion for M. ulcerans and for the water transmitted trematode Schistosoma mansoni occurred at around four and five years, respectively. Our data suggest that exposure to M. ulcerans intensifies strongly at the age when children start to have more intense contact with the environment, outside the small movement range of young children. Further results from our serological investigations in the Offin river valley also indicate ongoing transmission of Treponema pallidum, the causative agent of yaws.Entities:
Mesh:
Substances:
Year: 2016 PMID: 26808978 PMCID: PMC4726553 DOI: 10.1371/journal.pntd.0004387
Source DB: PubMed Journal: PLoS Negl Trop Dis ISSN: 1935-2727
Fig 1Study area.
Map of the Offin river basin in Ghana with selected study communities indicated as red dots.
Cut-off ODs for the S. mansoni and S. ratti ELISA.
| Pathogen | Antigen | ELISA cut-off (OD) | ||
|---|---|---|---|---|
| Negative | Equivocal | Positive | ||
| SEA | < 0.3 | 0.3–0.59 | ≥ 0.6 | |
| AWE | < 0.15 | 0.15–0.29 | ≥ 0.3 | |
| raw antigen | < 0.50 | 0.50–0.69 | ≥ 0.70 | |
aSoluble egg antigen
bAdult worm antigen extract
Population, study participants and serum positivity for the different antigens tested.
| Variables | Age in years | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11–20 | 21–30 | 31–40 | 41–50 | 51–60 | >60 | ||
| n = Total population (%) | 544 (2.7) | 694 (3.4) | 645 (3.2) | 661 (3.3) | 570 (2.8) | 534 (2.7) | 546 (2.7) | 570 (2.8) | 487 (2.4) | 614 (3.1) | 4,598 (22.8) | 3,827 (19) | 2,335 (11.6) | 1,507 (7.5) | 1,019 (5.1) | 976 (4.8) | |
| n = Participants (% of population) | 3 (0.6) | 16 (2.3) | 47 (7.3) | 52 (7.9) | 52 (9.1) | 35 (6.6) | 45 (8.2) | 55 (9.6) | 41 (8.4) | 56 (9.1) | 306 (6.7) | 183 (4.8) | 170 (7.3) | 110 (7.3) | 96 (9.4) | 85 (8.7) | |
| n = anti- | 0 (0) | 0 (0) | 1 (2) | 3 (6) | 2 (4) | 2 (6) | 3 (7) | 8 (15) | 3 (7) | 9 (16) | 49 (16) | 34 (19) | 43 (25) | 30 (27) | 25 (26) | 20 (24) | |
| n = anti- | 1/3 (33) | 7/15 (47) | 26/37 (70) | —- | —- | —- | —- | —- | —- | —- | —- | —- | —- | —- | —- | —- | |
| n = anti- | Both antigens | 0 (0) | 0 (0) | 1 (2) | 0 (0) | 0 (0) | 0 (0) | 1 (2) | 0 (0) | 1 (2) | 1 (2) | 5/142 (4) | 1/13 (8) | 1/14 (7) | 1/15 (7) | 1/14 (7) | 6/19 (32) |
| Treponemal antigen only | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 3 (6) | 0 (0) | 1 (2) | 1 (2) | 1 (2) | 3 (5) | 4/142 (3) | 2/13 (15) | 0 (0) | 2/15 (13) | 0/14 (0) | 5/19 (26) | |
| n = anti- | 0 (0) | 1 (6) | 1 (2) | 1 (2) | 1 (2) | 1 (3) | 0 (0) | 1 (2) | 2 (5) | 4 (7) | 15/142 (11) | 0/13 (0) | 1/14 (7) | 3/15 (20) | 1/14 (7) | 1/19 (5) | |
| n = anti- | SEA | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 1 (2) | 1 (3) | 1 (2) | 3 (5) | 0 (0) | 1 (2) | 16/142 (11) | 2/13 (15) | 1/14 (7) | 2/15 (13) | 0/14 (0) | 1/19 (5) |
| AWE | 0 (0) | 0 (0) | 1 (2) | 0 (0) | 0 (0) | 0 (0) | 1 (2) | 2 (4) | 0 (0) | 2 (4) | 15/142 (11) | 2/13 (15) | 4/14 (29) | 3/15 (20) | 0/14 (0) | 2/19 (11) | |
Total numbers and percentages of the study population, study participants and the proportions of serum samples tested positive in the different serological tests are shown.
ano child below one year participated in the study
bsoluble egg antigen
cadult worm antigen extract
Fig 2Age distribution of anti- M. ulcerans 18 kDa shsp serum IgG titers.
(A) Boxplots of OD values of 1:100 diluted serum samples tested in the anti- M. ulcerans 18 kDa shsp IgG specific ELISA by age group. The background cut-off value (OD<0.25) is indicated as a dotted line. The number of study participants for each age group (right y-axis) is visualized by grey dots connected by a grey line. (B) Sera obtained from a child participant (P1) at three different time points were tested for the presence of anti- M. ulcerans 18 kDa shsp serum IgG by Western Blot analysis. While the serum of the child tested positive at baseline, sero-reversion was observed after it had moved to a BU non-endemic community. A positive control serum (+) was included. The molecular weight standard (in kDa) is shown on the left of the blot.
Fig 3Design and results of a longitudinal sero-epidemiological study.
(A) Blood samples were taken in July 2013 from 1,352 inhabitants of the communities selected. All sampled individuals were followed up after either 6 (January 2014), 12 (August 2014) or 18 (January 2015) months. IgG titers against the M. ulcerans 18 kDa shsp were determined in serum samples collected at baseline and compared to titers in samples collected at different time points (TP) after 6 (B), 12 (C) or 18 (D) months. A straight line was drawn to visualize deviations between time points analyzed.
Fig 4Western blot analysis of anti- P. falciparum AMA-1 serum IgG responses in young children aged one (1), two (2) and three (3) years.
A number of sera from children aged one and two years already contained serum IgG against recombinant P. falciparum AMA-1 protein, as determined by Western Blot analysis. The molecular weight standard (in kDa) is shown next to the two blots that are separated by a vertical black line.
Fig 5Age distribution of anti- Strongyloides serum IgG titers.
All sera from children below the age of 11 years as well as a subset of sera from older age groups were tested for the presence of anti- Strongyloides antigen IgG by ELISA. The grey and the black dotted line indicate the cut-off OD values for equivocal and positive test results, respectively. The number of study participants for each age group (right y-axis) is visualized by grey dots connected by a grey line.
Fig 6Age distribution of anti- S. mansoni SEA and AWE serum IgG titers.
All sera from children below the age of 11 years and a subset of individuals of older age groups were tested for the presence of IgG against S. mansoni SEA (A) and AWE (B) by ELISA. The grey and the black dotted line indicate the cut-off OD values for equivocal and positive test results, respectively. The number of study participants for each age group (right y-axis) is visualized by grey dots connected by a grey line. The serum of the only young child testing positive in the AWE ELISA was reconfirmed to be positive by IFA. The serum of this child as well as a negative control serum labelled C- and a positive control serum labelled C+ is shown (C).